The UK needs a permanent ecosystem for rapidly developing, manufacturing, and supplying vaccines for future pandemics to ensure domestic resilience and security, a report from the now disbanded Vaccine Taskforce said.1 The report was originally prepared in December 2020 and submitted to the government, but not previously made public. Clive Dix, who headed the task force in 2020 and is now chief executive of drug company C4X Discovery, submitted the report to the House of Commons Science, Innovation, and Technology Committee as part of its inquiry into learnings from the covid-19 pandemic.2 The...